Cargando…
Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases
Gefitinib is regarded as a relatively safe agent for the treatment of an advanced non-small cell lung cancer (NSCLC). Pulmonary toxicity such as interstitial lung disease associated with gefitinib is uncommon with an estimated all time incidence around 1% worldwide. Moreover, a case of gefitinib ass...
Autores principales: | Ryu, Yon Ju, Chun, Eun Mi, Lee, Soon Nam, Shim, Sung Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955799/ https://www.ncbi.nlm.nih.gov/pubmed/24642811 http://dx.doi.org/10.3348/kjr.2014.15.2.300 |
Ejemplares similares
-
A Stepwise Diagnostic Approach to Cystic Lung Diseases for Radiologists
por: Lee, Kyu-Chong, et al.
Publicado: (2019) -
Pathological and clinical features of multiple cancers and lung adenocarcinoma: a multicentre study
por: Bertoglio, Pietro, et al.
Publicado: (2022) -
Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification
por: Hong, Jung Hee, et al.
Publicado: (2021) -
Pulmonary Cryptococcosis Mimicking Primary Lung Cancer with Multiple Lung Metastases
por: Kim, Yu Seung, et al.
Publicado: (2012) -
Placental Transmogrification of the Lung
por: Kim, Jin Woo, et al.
Publicado: (2013)